Adult Barrier Spray Brings Efficiencies and Cost Reduction in Prevention and Treatment of Incontinence-Associated Dermatitis 

Incontinence-associated dermatitis (IAD) is one of the most pervasive conditions in long-term care (LTC) settings. Studies have shown nearly half of the nursing home population being incontinent, with IAD symptoms present in nearly 23% of LTC patients. IAD is a major risk factor for the development of pressure ulcers, which has significant physical and economic impacts. 

Prevention of IAD is critical in decreasing the risk of pressure ulcers and associated complications such as infection and even loss of life. However, the effectiveness of protocols and products to prevent IAD and related complications is severely lacking. Current protocols typically use conventional creams and ointments after brief changes in adults with products that can be difficult to apply or remove, and may increase the risk of cross contamination.

Adult Barrier Spray White Paper

This white paper examines the results of a utilization study in a LTC setting using a new 10% zinc oxide adult barrier spray. 

In this white paper, health care professionals will learn: 

  • The economic impact of complications associated with IAD and the benefits of a skin care product that addresses issues of treatment costs in a clinical setting
  • The qualitative results of nursing staff involved in the utilization trial of a 10% zinc oxide adult barrier spray in a resident population of 56 participants
  • How touch free spray application of adult barrier protection can support the prevention and healing of IAD and decrease the risk of associated complications 


This white paper is generally written for health care professionals with an interest in product solutions. 

Sponsored by Mission Pharmacal Company

DISCLOSURES:

The primary research was conducted by Life Science Strategy Group LLC on behalf of Mission Pharmacal, developers of Dr. Smith’s Adult Barrier Spray. Neither the caregivers nor the long-term care facility where the study was conducted received remuneration as part of the study or the surveys. Mission Pharmacal provided the samples of the barrier spray during the study period.